With that in mind, could other drugs or hormones activate genetic programs similar to GLP-1
7TM Pharma Initiates Phase II Clinical Study with the Drug Candidate Obinepitide for the Treatment of Obesity
Estrogens play a pivotal role in the adult and developing brain (Morissette et al., 2008), exerting neuroprotective effects under homeostatic and pathologic conditions
We evaluated predictive performance with discrimination (C-statistic) and calibration (intercept, slope)
10.1002/mrd.23159 [DOI] [PubMed] [Google Scholar] Higa R., Roberti S., Mazzucco M
Following the successes of GLP-1 RAs, manufacturers have worked to produce similar outcomes with newer agents that affect the incretin pathways including not only GLP1 receptors but also GIP and glucagon receptors